Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter
- 6 July 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (14), 1224-1233
- https://doi.org/10.1038/sj.gt.3301231
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysisBiochimica et Biophysica Acta (BBA) - Biomembranes, 1998
- Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.Journal of Bioenergetics and Biomembranes, 1997
- A Conserved Downstream Element Defines a New Class of RNA Polymerase II PromotersPublished by Elsevier ,1995
- Differential utilization of multiple transcription start points accompanies the overexpression of the P-glycoprotein-encoding gene in Chinese hamster lung cellsGene, 1995
- Identification of a functional initiator sequence in the human MDR1 promoterBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Binding protein-dependent transport systemsJournal of Bioenergetics and Biomembranes, 1990
- The “initiator” as a transcription control elementCell, 1989
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- Isolation and expression of a complementary DNA that confers multidrug resistanceNature, 1986